Lenvatol 4mg Lenvatinib Capsule

Lenvatol 4mg Lenvatinib Capsule is a prescription targeted anti-cancer medication used in the treatment of thyroid cancer, liver cancer (hepatocellular carcinoma), kidney cancer, and certain types of endometrial cancer. It contains Lenvatinib, a tyrosine kinase inhibitor (TKI) that works by blocking specific proteins involved in tumor growth and the formation of new blood vessels that supply cancer cells. By inhibiting these pathways, Lenvatol 4mg Capsule helps slow cancer progression and supports effective disease management. Taken orally under the supervision of an oncology specialist, it may be prescribed alone or in combination with other cancer therapies depending on the patient's condition. Regular monitoring of blood pressure, liver function, and overall health is important during treatment to ensure safety and effectiveness. Patients should use Lenvatol 4mg Lenvatinib Capsule only as directed by their healthcare provider.